Cancer
-
Rectal Cancer Deaths Rising Faster Than Colon Cancer in Young Americans
Something is changing inside the bodies of people born after 1980. Doctors can see it in the data. Rectal cancer, a disease…
-
Rectal Cancer Deaths Rise Among Young Adults, Data Shows
For a 34-year-old in New York, the blood in the stool was easy to explain away. Hemorrhoids, maybe. A bad reaction to…
-
New Study Links Very Low Testosterone to Higher Risk of Cancer Death
For years, doctors have told men that low testosterone is bad for their sex drive, their energy, their mood. Now comes word…
-
Rural Counties Cut Cancer Deaths Far Less Than Big Cities Since 1991, Studies Show
The gap in cancer survival between urban and rural America is not just a statistic — it carries real, measurable consequences for…
-
21 Virginia Cancer Specialists Physicians Named to Washingtonian Top Doctors Hall of Fame
Twenty-one oncologists at Virginia Cancer Specialists have been inducted into the Washingtonian “Top Doctors” Hall of Fame. The distinction is not given…
-
Johann Lafer Says Lymph Nodes Are Shrinking After Four Chemotherapy Cycles
HAMBURG — The lymph nodes are shrinking. For Johann Lafer, that is the difference between a treatment that is working and one…
-
Montreal researchers identify molecular mechanism that sabotages cancer immunotherapy
MONTREAL — For a significant number of cancer patients, the most advanced immunotherapies simply stop working. Tumors that initially shrink eventually grow…
-
Johann Lafer Says Lymphoma Cannot Be Cured After Early Chemotherapy Gains Shrank His Lymph Nodes
Understanding Lafer’s Condition Lafer was diagnosed with an indolent, low-grade, non-Hodgkin lymphoma earlier this year, with the diagnosis being made public in…
-
Montreal team finds SLAMF6 immune brake that may explain cancer drug resistance
MONTREAL — Scientists at the Montreal Clinical Research Institute (IRCM) have identified a previously unknown immune-suppressing mechanism that may explain why some…
-
New Drug Targets ‘Undruggable’ KRAS in Pancreatic Cancer
For many years the KRAS gene was regarded as an impossible target for drug development. Its surface lacks distinct pockets, giving medicinal…
-
Columbia and Tübingen Researchers Find Protein NFIL3 Drives CAR T-Cell Exhaustion
Engineered immune cells known as CAR‑T cells have revolutionized treatment for blood cancers, yet their impact on solid tumors such as breast,…
-
Cancer Cells Hiding From Killer T Cells Become Targets for Helper T Cells
For decades, the prevailing view in oncology held that cancer cells that lose MHC class I molecules become invisible to cytotoxic CD8⁺…
-
Scientists Capture 3D View of T Cells Attacking Cancer
Geneva, 5 June – A team of researchers from the University of Geneva and the CHUV/UNIL collaboration has produced the first detailed…
-
Cancer Society Adds Blood Test to Colorectal Screening, but Only for Those Declining Other Tests
United States, May 27, 2026 — cyberinktimes.com — The American Cancer Society (ACS) announced on May 27, 2026, that the Guardant Health…
-
Keytruda in Cancer Care: How Pembrolizumab Works and Which Side Effects to Watch
Patients receiving pembrolizumab, the immunotherapy drug sold as Keytruda, commonly report a range of side effects including fatigue, musculoskeletal pain, diarrhea, nausea,…
-
Dana-Farber Retracts and Corrects Dozens of Papers, Then CEO Laurie Glimcher Steps Down
BOSTON, USA — Dana-Farber Cancer Institute is facing a leadership crisis and a wave of scientific corrections after an investigation uncovered research…
-
FDA Approves Lazertinib With Amivantamab as First-Line Treatment for EGFR Lung Cancer
For patients with a common form of lung cancer, a new treatment option arrived in the United States on August 15, 2024.…
-
FDA Approves Voranigo, a Daily Pill That Delays Progression of Low-Grade Glioma
Each year, about 1,500 Americans receive a diagnosis of grade 2 glioma, a slowly progressing yet aggressive brain tumor. Until now, treatment…
-
FDA Approves Imetelstat for Treating Myelodysplastic Syndromes with Anemia
In a pivotal shift for the cancer treatment landscape, the US Food and Drug Administration (FDA) granted approval on June 15, 2024,…
-
FDA Approves Lung Cancer Drug Augtyro for ROS1-Positive Tumors, Trial Shows Responses
The U.S. Food and Drug Administration granted approval on November 15, 2023, for Repotrectinib, marketed as Augtyro, to treat a defined group…
-
FDA Grants Accelerated Approval to Talquetamab, a T-Cell Engager for Myeloma
For patients with multiple myeloma who have run out of options, August 15, 2023, changed the calculus. That day, regulators in the…
-
FDA Grants Accelerated Approval to Elrexfio for Heavily Treated Multiple Myeloma
/ HTML. So we need headings maybe and paragraphs . Must not add any extra info. Must keep facts: FDA approved Elranatamab…
-
European Commission Approves Niraparib and Abiraterone Tablet for BRCA-Mutated Metastatic Prostate Cancer
European Union, April 19, 2023 — cybernewschronicle.com — Niraparib/abiraterone acetate, a fixed-dose combination anti-cancer medication, has been approved for the treatment of…
-
US Approves New Gene Therapy For Bladder Cancer Treatment
In December 2022 the U.S. Food and Drug Administration granted approval to nadofaragene firadenovec, sold under the brand name Adstiladrin, marking the…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992